The Washington Times
  • Subscribe
  • Times News Services
  • RSS
  • Mobile Headlines
  • e-edition
  • E-MAIL ALERTS
  • REGISTER
  • LOG IN
  • E-MAIL ALERTS
  • WELCOME
  • Your Profile
  • Log Out
  • Front Page Image
  • Classifieds
  • Autos
  • Real Estate
  • Jobs
  • Special Sections
  • Customer Service
  • Home
  • News
  • Opinion
  • Sports
    • NFL
    • NBA/WNBA
    • MLB
    • NHL
    • Tennis
    • Golf
    • Motorsports
    • Soccer
    • NCAA
    • Olympics
    • Outdoors
    • Other
  • Culture
    • Home & Living
    • Family & Kids
    • Fashion
    • Food
    • Travel
    • Health
    • Washington Visitors
    • Books
    • Military History
    • Life
    • Auto
    • TV Listings
    • Movie Listings
    • Death Notices
    • Entertainment
  • Themes
  • Communities
  • Shopping
    • Stores
    • Coupons
    • Daily Double
    • Promotion
    • How It Works
  • Videos
    • Two Guys
    • Birnbaum on Washington
    • Liz Glover
    • Amanda Carpenter
    • Morning Briefing
    • Documentaries
    • Joe Giganti
    • Video Game Minute
  • Podcasts
    • About Headlines
    • Audio and Radio
    • America's Morning News
  • Sports

    KNOTT: Pollin honored as a D.C. treasure

  • Sports

    Jamison lights fire under Wizards

  • Politics

    Uninvited White House guests met Obama in line

  • Sports

    Wife aids Woods after SUV crash

  • National

    Volunteers for drug trials hard to find

  • Business

    Dubai debt crisis rocks U.S., Asia markets

  • World

    Piracy threatens fishermen in Yemen

Home » News » Editor Favorites

Sunday, June 22, 2008

Ethics of military drug testing questioned

Rate this story

Average 0.00
after 0 votes
Login or register to rate this story

Degree of 'voluntary' participation raises concerns

  • Font Size -+
  • Print
  • Email
  • Comment
  • Tweet this!
  • Share
  • Article
  • Comments ()
  • Click-2-Listen
  • Videos

More Editor Favorites Stories

  • KNOTT: Pollin honored as a D.C. treasure
  • Jamison lights fire under Wizards
  • Uninvited White House guests met Obama in line
  • Wife aids Woods after SUV crash

By David R. Sands

Colombian and Indonesian troops have been drafted to test new anti-malaria drugs. South African researchers used Tanzanian soldiers to study the effectiveness of an unorthodox treatment for HIV/AIDS.

And a trial conducted on some 2,000 Nepalese soldiers for a new hepatitis-E vaccine by a major U.S. drug company sparked public protests and complaints that the Nepalese troops were being used as human guinea pigs.

An investigation by The Washington Times and ABC News, which on Tuesday reported a troubled U.S. government program using military veterans to test potentially dangerous drugs, has focused new attention on what medical ethicists say is an especially difficult problem. The U.S. military is not the only one that has had to deal with the consequences.

Military personnel and veterans represent two particularly tempting populations for medical study, researchers say. A large sample of participants, complete with detailed medical histories and personal data, can be quickly assembled. Their behavior, travel and personal habits are far easier to control during the study period.

But that high level of control also makes military medical testing a moral minefield, ethicists say. Just how much freedom does a soldier, sailor, airman or Marine in the ranks have to refuse to participate in a medical trial when asked by a superior officer?

"Considering that the majority of defense-related research is 'non-therapeutic' and ... is typically carried out on healthy volunteers, the standard of legal consent is high," according to recent study of military medical issues by lawyer Ashley R. Melson.

Earlier this year, Britain's Ministry of Defense paid out more than $5.9 million to settle claims from 369 veterans subjected to tests at the government's Porton Down chemical-warfare center. The veterans claimed in a lawsuit that they had been exposed to nerve gas and mustard gas in trials there, leading to a wide variety of health problems.

Porton Down, believed to be the oldest chemical-warfare research site in the world, has tested some 25,000 British servicemen since its establishment in 1916.

In Nepal in the mid-1990s, an institute of the Walter Reed Army Institute of Research set up a field station to test a new hepatitis vaccine licensed to pharmaceutical giant GlaxoSmithKline.

After popular protests forced the cancellation of plans to test the vaccine on Nepalese citizens, researchers in 2001 turned to 2,000 Royal Nepalese Army soldiers at a military hospital in Katmandu.

The U.S. Embassy strongly defended the tests, saying the Nepalese soldiers had volunteered for the trial and denying a link between the research and U.S. military aid to the poor Asian nation. The U.S. government had given tens of millions of dollars to the government as it battled a Maoist insurgency.

But critics said the Nepalese military was unlikely to refuse a request from its biggest patron to provide recruits for the medical study.

The money, training and equipment supplied by the U.S. military to Nepal's army "threatened the voluntary nature of the institutional and individual participation in the trial," medical researcher Jason Andrews wrote in the American Journal of Bioethics.

cRita Tiwari contributed to this report.

[Get Copyright Permissions] Click here for reprint permissions!
Copyright 2009 The Washington Times, LLC

Post a comment

There are comments on this article, submit your opinion!

Please login or register to post a comment

Ask a Question

You Report

Do you have another point of view, photos, audio, video or more information about a story?

Top Stories

Most Read

  1. EDITORIAL: Hiding evidence of global cooling
  2. EDITORIAL: The global-cooling cover-up
  3. Climate 'czar' says hacked e-mails don't change anything
  4. Wife aids Woods after SUV crash
  5. PRUDEN: Trouble afoot for high priests
More Top Stories »
  1. In tobacco-loving Virginia, bars give up the habit
  2. Grade-schooler unearths fossil at dinosaur park
  3. Robotic hamster holiday craze
  4. Fenty's approval in D.C. divided by race
  5. Climate czar rejects doctored data claims

Most Shared

  1. PRUDEN: Trouble afoot for high priests
  2. EDITORIAL: The global-cooling cover-up
  3. EDITORIAL: Hiding evidence of global cooling
  4. University bubble bursting?
  5. Robotic hamster holiday craze
More Top Stories »
  1. We ain't seen nothing yet
  2. Climate 'czar' says hacked e-mails don't change anything
  3. The United Socialist States of America
  4. Grayson's Senate filibuster petition faulted
  5. CHANDLER: The Cloward-Piven strategy

Most Commented

  1. EDITORIAL: The global-cooling cover-up
  2. Climate 'czar' says hacked e-mails don't change anything
  3. PRUDEN: Trouble afoot for high priests
  4. Crashers probe may become criminal investigation
  5. EDITORIAL: Hiding evidence of global cooling
More Top Stories »
  1. Fenty's approval in D.C. divided by race
  2. Grayson's Senate filibuster petition faulted
  3. Ads add heat to health care debate
  4. On Afghan war decision, stakes never higher for Obama
  5. University bubble bursting?

Listen to Washington Times Radio

  • America's Morning News

    with John McCaslin and Melanie Morgan

Question of the day

Are you planning to go shopping today?

Blogs & Columns

  • Hot Button Blog

    RNC: Breast cancer recommendations may lead to 'rationing'

  • Belief Blog

    Evangelicals OK civil disobedience

  • Out of Context

    Foods that might kill libido

  • On the Fly

    United lifts some 'award' blocking

  • Technology

    Facebook wins round against phishing spammer

  • Redskins 360

    Gray staying put

  • SNOBlog

    Beyond 'Woody'

Videos

Advertising Links
TWT Store
  • e-edition
  • Print Edition
  • Weekly Washington Times
TWT Affiliates
  • Middle East Times
  • Golf
  • UPI
  • Arbor Ballroom
  • Washington Times Global
  • About TWT
  • Press Room
  • F.A.Q.
  • Work for TWT
  • Advertise
  • Sponsors
  • Contact Us
  • Privacy Policy
  • Site Map

All site contents © Copyright 2009 The Washington Times, LLC.